0

RespireRx Pharmaceuticals Inc (RSPI) – Financial and Strategic SWOT Analysis Review

Publisher Name :
Date: 6-Jun-2017
No. of pages: 44

RespireRx Pharmaceuticals Inc (RSPI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

RespireRx Pharmaceuticals Inc (RespireRx), formerly Cortex Pharmaceuticals, Inc., is a pharmaceutical company which focuses on the discovery, development and commercialization of innovative products for the treatment of various respiratory disorders. It has two drug platforms, each with a clinical stage compound directed at breathing disorders. The company’s respiratory disease product pipeline includes compounds in various development stages for the treatment of obstructive sleep apnea (OSA), chronic and post-surgical central sleep apnea (CSA), opioid induced respiratory depression, spinal cord injury, and induced respiratory depression. Its lead product, Dronabinol is an oral capsule drug product in Phase II trials for the treatment of OSA. RespireRx is headquartered in Glen Rock, New Jersey, the US.

RespireRx Pharmaceuticals Inc Key Recent Developments

Nov 15,2016: RespireRx Pharmaceuticals Files September 30, 2016 Quarterly Report on Form 10-Q
Aug 15,2016: RespireRx Pharmaceuticals Files June 30, 2016 Quarterly Report on Form 10-Q
May 17,2016: RespireRx Pharmaceuticals Files March 31, 2016 Quarterly Report on Form 10-Q
Apr 01,2016: RespireRx Pharmaceuticals, the University of Alberta and the University of Florida Provide Update on Collaborative Research Activities
Mar 29,2016: RespireRx Pharmaceuticals Files December 31, 2015 Annual Report on Form 10-K

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of content
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
RespireRx Pharmaceuticals Inc - Key Facts 5
RespireRx Pharmaceuticals Inc - Key Employees 6
RespireRx Pharmaceuticals Inc - Key Employee Biographies 7
RespireRx Pharmaceuticals Inc - Major Products and Services 8
RespireRx Pharmaceuticals Inc - History 9
RespireRx Pharmaceuticals Inc - Company Statement 11
RespireRx Pharmaceuticals Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 - Company Analysis 14
RespireRx Pharmaceuticals Inc - Business Description 14
RespireRx Pharmaceuticals Inc - SWOT Analysis 15
SWOT Analysis - Overview 15
RespireRx Pharmaceuticals Inc - Strengths 15
RespireRx Pharmaceuticals Inc - Weaknesses 16
RespireRx Pharmaceuticals Inc - Opportunities 17
RespireRx Pharmaceuticals Inc - Threats 18
RespireRx Pharmaceuticals Inc - Key Competitors 19
Section 3 - Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 - Company's Lifesciences Financial Deals and Alliances 26
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
RespireRx Pharmaceuticals Inc, Recent Deals Summary 28
Section 5 - Company's Recent Developments 29
Nov 15, 2016: RespireRx Pharmaceuticals Files September 30, 2016 Quarterly Report on Form 10-Q 29
Aug 15, 2016: RespireRx Pharmaceuticals Files June 30, 2016 Quarterly Report on Form 10-Q 31
May 17, 2016: RespireRx Pharmaceuticals Files March 31, 2016 Quarterly Report on Form 10-Q 33
Apr 01, 2016: RespireRx Pharmaceuticals, the University of Alberta and the University of Florida Provide Update on Collaborative Research Activities 36
Mar 29, 2016: RespireRx Pharmaceuticals Files December 31, 2015 Annual Report on Form 10-K 37
Section 6 - Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
RespireRx Pharmaceuticals Inc, Key Facts 5
RespireRx Pharmaceuticals Inc, Key Employees 6
RespireRx Pharmaceuticals Inc, Key Employee Biographies 7
RespireRx Pharmaceuticals Inc, Major Products and Services 8
RespireRx Pharmaceuticals Inc, History 9
RespireRx Pharmaceuticals Inc, Subsidiaries 13
RespireRx Pharmaceuticals Inc, Key Competitors 19
RespireRx Pharmaceuticals Inc, Ratios based on current share price 20
RespireRx Pharmaceuticals Inc, Annual Ratios 21
RespireRx Pharmaceuticals Inc, Annual Ratios (Cont...1) 22
RespireRx Pharmaceuticals Inc, Interim Ratios 24
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
RespireRx Pharmaceuticals Inc, Recent Deals Summary 28
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43

List of Figures
RespireRx Pharmaceuticals Inc, Performance Chart (2012 - 2016) 23
RespireRx Pharmaceuticals Inc, Ratio Charts 25
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
RespireRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2020 RnR Company Profiles. All rights reserved.